A First Treatment for Celiac Disease?

Celiac disease is of the most common auto-immune diseases in the world. The only current treatment is maintaining a strict gluten-free diet. Join host, Geoff Wall, as he discusses the results of a phase 2 study investigating a novel pharmacologic treatment of Celiac disease. The GameChangerCeliac disease is common and has a myriad of symptoms. A new drug may offer a way for patients with Celiac disease to eat gluten without issue.Show Segments00:00 - Introductions00:50 - The Effects of Celiac Disease03:45 - Why Celiac Causes Problems09:08 - Latiglutenase Study Background14:48 - The GameChanger: Latiglutenase Study Results19:11 - Connecting to Practice21:31 - Closing RemarksHostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferences and ResourcesMurray JA, Syage JA, Wu TT, et al. Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge. Gastroenterology. 2022 Dec;163(6):1510-1521.e6. doi: 10.1053/j.gastro.2022.07.071. Epub 2022 Aug 2. PMID: 35931103; PMCID: PMC9707643.Redeem your CPE or CME hereCPE (Pharmacist)CME (Physician) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipPrescribers: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the extraintestinal manifestations of Celiac disease2. Discuss the Murray et al study and its implications in patients with Celiac disease0.05 CEU/0.5 HrUAN: 0107-0000-23-024-H01-PInitial release date: 01/16/2023Expiration date: 01/16/2024Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram